mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.4 |
mRNA |
IC-87114 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
RAF265 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
BRD-K79669418 |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.4 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
regorafenib |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |